Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...

Roorkee: Researchers at Indian Institute of Technology Roorkee (IIT Roorkee) have developed a high-diversity antibody ...

Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...

Neil McIntosh looks at the use of 'monoclonal antibodies', rather than drugs, to treat our pets - especially those with ...

Antibodies Inc., a leading supplier of validated life science research reagents, today announced the availability of its Recombinant Guinea Pig RBPMS Antibody (Clone OTI3B7-GP, Cat. No. 1834-RBPMS)—a ...

ITI-5000 utilizes nucleic acid vaccine constructs engineered to preferentially deliver tumor-associated antigens (TAAs) to the MHC II compartment via LAMP-1, potentially enhancing antigen presentation ...

For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.

Company to Initiate First-in-Human Phase 1 Clinical Trial in Q2 2026ROCKVILLE, Md.--(BUSINESS WIRE)--#Clinicaltrials--Immunomic Therapeutics, Inc. (“ITI”), a privately held clinical-stage ...

T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells. The modality has remained a big draw for Big Pharma, with Eli Lilly penning ...

A research team engineered a rigid, nanometer-scale protein module to address the challenge of measuring antibody flexibility ...

The U.S. bispecific antibodies market is booming due to increased cancer and autoimmune diseases, FDA approvals, and ...

The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...